MedPath

Immunis.ai

🇺🇸United States
Ownership
Private
Employees
2
Market Cap
-
Website
https://immunis.ai

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

SNAPS Breast Cancer Patient Study Breast Cancer Patients

Not yet recruiting
Conditions
Breast Cancer
Breast Cancer Female
First Posted Date
2022-05-11
Last Posted Date
2024-03-06
Lead Sponsor
Immunis.AI
Target Recruit Count
500
Registration Number
NCT05370300
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Recruiting
Conditions
Prostate Cancer Aggressiveness
First Posted Date
2019-08-09
Last Posted Date
2024-03-06
Lead Sponsor
Immunis.AI
Target Recruit Count
2000
Registration Number
NCT04052048
Locations
🇺🇸

Comprehensive Urology, Royal Oak, Michigan, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.